Global Anxiety and Panic Disorders Drugs Market 2017-2021

This market research study identifies AstraZeneca, Eli Lilly, GlaxoSmithKline, and Pfizer as the leading players in the global anxiety and panic disorders drugs market. A comprehensive analysis of this market is also presented by the drug class (antidepressant drugs market, anxiolytic drugs market, and others) and by geography (the Americas, APAC, and EMEA).

Global anxiety and panic disorders drugs market forecast

As per the Technavio’s market research report, the global anxiety and panic disorders drugs market is expected to grow at a steady rate and post a CAGR of close to 2% during the forecast period. The advancements in neurogenetics will drive the growth prospects for the global anxiety and panic disorders drugs market from 2017 to 2021. Scientific advancements such as genetic engineering and new DNA-editing technologies have enabled researchers to gain a better insight of the genes associated with the progression of anxiety disorders, which helps in the development of target therapies to treat them. The gene NTRK3 is responsible for causing panic disorder because the deregulation of this gene leads to malfunctioning of the fear-related memory system. The study of this gene under neurogenetics enables the researchers to come up with therapies that directly stimulate the affected area of the brain and produce pharmacological effects.

Get A Free Sample 

The synergistic effects of medication aided with neuromodulation devices are one of the key anxiety and panic disorders drugs market trends responsible for the market’s growth during the projected period. The neuromodulation is a novel psychiatric treatment and when it is taken along with the traditional therapeutic regimen, provides a complete treatment for anxiety and panic disorders, which will further boost the acceptance of these drugs in the market.

Competitive landscape and key vendors

The global anxiety and panic disorders drugs market is highly fragmented due to the presence of a number of large and small players. These vendors are increasingly competing against each other due to factors such as emerging indications or applications, major patent expiries, and the rising prevalence of anxiety and panic disorder in the developed and other developing countries. Furthermore, some of these vendors are increasingly manufacturing a wide range of pharmaceutical products for various segments such as respiratory, inflammation and autoimmunity, cardiovascular and metabolic diseases, oncology, infection, neuroscience, and gastrointestinal.

Key vendors in this market are 

• AstraZeneca
• Eli Lilly
• GlaxoSmithKline
• Pfizer

Other prominent vendors in the market include Azevan Pharmaceuticals, Baxter, Bristol-Myers Squibb, and F. Hoffman-La Roche.

Segmentation by drug class and analysis of the anxiety and panic disorders drugs market

• Antidepressant drugs market
• Anxiolytic drugs market

Based on the anxiety and panic disorders drugs market statistics, the anxiety and panic disorders antidepressant drugs segment contributed to the majority of the revenue to the overall market and will continue to be the major revenue contributor to the market during the next four years as well. The introduction of the newer selective serotonin reuptake inhibitor (SSRIs) with more safer side effects is driving the market segment’s growth in the coming years. Brintellix was approved by the US FDA in September 2013 for the treatment of depression. 

Segmentation by geography and analysis of the anxiety and panic disorders drugs market

• Americas
• APAC
• EMEA

According to this market research report, the Americas accounted for the majority market share during 2016 and will continue to dominate the market in the coming years. The rising number of visits to a psychiatrist and the increasing prevalence of the anxiety disorders in this region will accelerate the rate of revenue generation in the market.

Want a bigger picture? Try a FREE sample of this report now!

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.   

Key questions answered in the report include

• What will the market size and the growth rate be in 2021?
• What are the key factors driving the global anxiety and panic disorders drugs market?
• What are the key market trends impacting the growth of the global anxiety and panic disorders drugs market?
• What are the challenges to market growth?
• Who are the key vendors in the global anxiety and panic disorders drugs market?
• What are the market opportunities and threats faced by the vendors in the global anxiety and panic disorders drugs market?
• What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
• What are the key outcomes of the five forces analysis of the global anxiety and panic disorders drugs market?

Technavio also offers customization on reports based on specific client requirement.